Biosante Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $54M | 590k | 91.60 |
| 2025-06-30 | $26M | 405k | 65.25 |
| 2025-03-31 | $18M | 264k | 66.95 |
| 2024-12-31 | $33M | 595k | 55.28 |
| 2024-09-30 | $17M | 287k | 59.66 |
| 2024-06-30 | $2.0M | 32k | 63.50 |
| 2024-03-31 | $1.2M | 18k | 69.13 |
| 2023-12-31 | $1.0M | 19k | 55.14 |
| 2023-09-30 | $359k | 6.2k | 58.06 |
| 2023-06-30 | $1.7M | 32k | 54.00 |
| 2023-03-31 | $465k | 12k | 39.72 |
| 2022-12-31 | $274k | 6.8k | 40.23 |
| 2022-09-30 | $1.0k | 44 | 22.73 |
| 2022-03-31 | $14k | 481 | 29.11 |
| 2021-12-31 | $393k | 5.9k | 66.67 |
| 2021-09-30 | $0 | 1.6k | 0.00 |
| 2021-06-30 | $157k | 2.4k | 66.67 |
| 2021-03-31 | $144k | 4.0k | 36.22 |
| 2020-12-31 | $147k | 5.0k | 29.44 |
| 2020-09-30 | $226k | 8.0k | 28.26 |
| 2020-06-30 | $581k | 18k | 32.31 |
| 2020-03-31 | $311k | 7.6k | 40.77 |
| 2019-12-31 | $954k | 15k | 62.75 |
| 2019-09-30 | $722k | 9.7k | 74.63 |
| 2019-06-30 | $360k | 4.3k | 83.97 |
| 2019-03-31 | $8.0k | 120 | 66.67 |
| 2018-12-31 | $7.8k | 218 | 35.71 |
| 2018-09-30 | $98k | 1.8k | 55.56 |
| 2018-06-30 | $45k | 669 | 67.02 |
| 2018-03-31 | $93k | 1.5k | 61.54 |
| 2017-12-31 | $19k | 296 | 64.19 |
| 2017-09-30 | $147k | 2.8k | 52.61 |
| 2017-06-30 | $105k | 2.2k | 47.00 |
| 2017-03-31 | $228k | 4.6k | 49.52 |
| 2016-12-31 | $418k | 6.9k | 60.60 |
| 2016-09-30 | $1.3M | 19k | 66.36 |
| 2016-06-30 | $812k | 15k | 55.85 |
| 2016-03-31 | $65k | 1.9k | 33.75 |
| 2015-12-31 | $88k | 2.0k | 45.01 |
| 2015-09-30 | $2.0k | 59 | 33.90 |
| 2015-03-31 | $170k | 2.7k | 62.52 |